Top Markets
#1 Akedo Akedo +12.06%
#2 MarsCoin MarsCoin +11.66%
#3 EXOD EXOD +9.04%
#4 Solstice Solstice +8.28%
#5 ETHGas ETHGas +7.54%
#6 龙虾 (Lobster) 龙虾 (Lobster) +6.80%
#7 Seeker Seeker +5.97%
#8 DexNet DexNet +5.76%
#9 peaq peaq +5.53%
#10 Official Trump Official Trump +5.49%
Coin of the day
Akedo Akedo
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Damora Therapeutics, Inc. Damora Therapeutics, Inc.

Damora Therapeutics, Inc.

DMRA
Peringkat dalam Saham #6692
Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering... Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering innovative small molecule therapeutics. These treatments are specifically engineered to address core biological pathways implicated in both cancer and fibrotic disorders. The firm is also actively developing small molecule inhibitors targeting galectin-3 and LOXL2. Established in 2011 by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye, its corporate operations are based in Boston, Massachusetts.
Harga Saham
$30.90
Terakhir disinkronkan: 2026-08-27
Kapitalisasi Pasar
$1.90B
Perubahan (1 hari)
1.68%
Perubahan (1 tahun)
859.63%
Negara
US
Perdagangan Damora Therapeutics, Inc. (DMRA)

Kategori

Healthcare
Riwayat hasil dividen untuk Damora Therapeutics, Inc. (DMRA)
Hasil dividen (TTM) dari Damora Therapeutics, Inc. (simbol saham: DMRA) per 2026: 0
Rata-rata hasil dividen selama 5 tahun terakhir: 0.00%
Riwayat hasil dividen untuk Damora Therapeutics, Inc. (DMRA) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing
Perusahaan Hasil Dividen Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH